A detailed history of Sunbeam Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sunbeam Capital Management, LLC holds 2,389 shares of LLY stock, worth $2.44 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
2,389
Previous 2,328 2.62%
Holding current value
$2.44 Million
Previous $1.81 Billion 0.45%
% of portfolio
1.13%
Previous 1.37%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$625.65 - $812.69 $38,164 - $49,574
61 Added 2.62%
2,389 $1.82 Billion
Q2 2025

Jul 23, 2025

BUY
$713.71 - $898.95 $358,996 - $452,171
503 Added 27.56%
2,328 $1.81 Billion
Q1 2025

May 06, 2025

BUY
$725.72 - $929.72 $1,451 - $1,859
2 Added 0.11%
1,825 $1.51 Billion
Q4 2024

Feb 24, 2025

BUY
$727.2 - $932.06 $1.32 Million - $1.7 Million
1,822 Added 182200.0%
1,823 $1.41 Billion
Q4 2024

Feb 20, 2025

BUY
$727.2 - $932.06 $727 - $932
1 New
1 $1.41 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sunbeam Capital Management, LLC Portfolio

Follow Sunbeam Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbeam Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunbeam Capital Management, LLC with notifications on news.